This funding supports innovative research projects that explore synthetic vulnerabilities conditionally paired with tumor responses to radiation therapy. The program emphasizes precision and reproducibility in developing radiation-synthetic combination strategies that leverage tumor-specific vulnerabilities and molecularly targeted agents to improve therapeutic outcomes. Projects may be exploratory or longer-term research, aiming to enhance precision medicine in oncology.
Eligible applicants include a wide range of U.S. government entities, educational institutions, nonprofits, for-profit organizations, tribal governments, and certain non-U.S. entities. Specific eligibility details are extensive and include state, county, city governments, and various organizations.
